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Summary. Surgery in anticoagulated patients is problem-
atic. Coumarin therapy is often discontinued or reversed to
reduce the perioperative bleeding risk. Meanwhile, the
thromboembolic risk is enhanced. We sought to determine
the frequency of bleeding and thromboembolism in antico-
agulated patients undergoing routine surgery and to
investigate the role of patient characteristics and the level of
anticoagulation. We studied patients who attended the
Leiden Anticoagulation Clinic for treatment relating to
mechanical heart valve prostheses, atrial flbrillation or
myocardial infarction and underwent surgery at the Leiden
University Medical Centre between 1994 and 1998. Out-
come events were bleeding and thromboembolism in the
perioperative period. Seventy-two complications occurred in
603 interventions, yielding an overall frequency of 11-9%
[95% confidence interval (CI): 9-3-14-9], 9-5% (n = 57) for
haemorrhage and 2-5% (n = 15) for thromboembolism.
Younger patients tended to have more complications [odds
ratio (OR) for >65 years of age: 0-5, 95% CI 0-3-1-0] äs did
patients with atrial fibrillation (OR for atrial fibrillation
versus mechanical heart valve prostheses: 1-8, 95% CI
0-8-4-2). High postoperative levels of anticoagulation were
associated with a slightly increased risk of complications
[OR international normalized ratio (INR) > 3 vs. INR < 2:
1-3, 95% CI 0-6-3-0]. We conclude that routine surgery in
anticoagulated patients yields a high perioperative bleeding
and thromboembolic risk. While neither patient character-
istics nor the level of anticoagulation appeared to play a
major role in the occurrence of complications, the risk was
clearly associated to the type of surgery, with the highest




Over recent decades, oral anticoagulant therapy with
coumarin derivatives has proved to be effective in the
prevention of arterial and venous thromboembolism. Now-
adays, coumarins are recommended for the prevention of
stroke in patients with atrial fibrillation (Albers et cd, 2001),
heart valve disease and mechanical heart valve prostheses
(Stein et al, 2001) äs well äs for the primary and secondary
prevention of deep vein thrombosis and pulmonary embol-
ism (Hyers et al, 2001). Moreover, oral anticoagulation has
been shown to be effective in the prevention of stroke and
recurrent myocardial infarction in patients with ischaemic
heart disease (ASPECT Research Group, 1994; Smith et al,
1990). In particular, patients with a high risk of arterial
thromboembolism are often treated with anticoagulants for
a longer period, sometimes even for life, which leads to
several clinical dilemmas. This report focuses on anticoagu-
lant policy in relation to surgery.
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In day-to-day practice, oral anticoagulant treatment is
often discontinued or reversed in case of a surgical or
medical procedure to reduce the risk of haemorrhage during
and shortly after the Intervention. This practice increases
the risk of thromboembolism with added risk from the
surgical procedure itself. Because of the lack of data,
physicians have limited other guidelines for the manage-
ment of anticoagulant therapy than personal clinical
experience (Douketis et al, 1999, 2000).
A few attempts have been made to describe the occur-
rence of haemorrhage and thromboembolism in relation to
surgery. These studies, however, were limited to specific
surgical procedures (Chakravarti & MacDermott, 1998;
Morris & Eider, 2000), to a limited number of events
(Caliendo et al, 1999) or to one particular complication
(Limburg et al, 1998). Recent review articles have presented
recommendations that are mainly based on theoretical
argumentation (Kearon & Hirsh, 1997; Heit, 2001). We feit
that additional clinical data were needed to evaluate the
overall effect of oral anticoagulation on the occurrence of
untoward events related to surgery. Therefore, we deter-
mined the frequency of complications in anticoagulated
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patients undergoing surgery at the Leiden University
Medical Centre and mvestigated the role of patient charac
tenstics and the level of anticoagulation
METHODS
Patients In the penod between 1994 and 1998, we
performed a prospective study among 4200 patients of the
Leiden Anticoagulation Chnic to determme the optimal level
of oral anticoagulation in patients with potential cardiac
sources of embohsm atrial flbnllation, mechanical heart
valve prostheses and myocardial infarction Because of the
extensive follow-up of the anticoagulation clinic we were
able to register over 3200 hospital admissions dunng the
time-window of the study We collected discharge letters for
these ddmissions and selected all 603 admissions to the
Leiden University Medical Centre dunng which a medical or
surgical Intervention had been carried out for which oral
anticoagulation is usually interrupted We studied the
discharge letters and checked whether a bleedmg or
thromboembohc comphcation was mentioned If such an
event had occurred, we studied the füll medical chart An
overview of the interventions is provided m Table I
Cases and controls In the group of patients with inter-
ventions we calculated the frequencies of bleedmg and
thromboembohc events Moreover, we performed a nested
case-control study to mvestigate m detail the factors which
contnbuted to the occurrence of comphcations
All patients who had a bleedmg or thromboembohc event
in the perioperative penod (from 2 days prior to the
Intervention until 3 weeks afterwards) were mcluded äs
cases For every case we randomly chose two controls from
the group of patients who also had surgery at our hospital
but had not suffered any comphcation Each patient was
mcluded äs a case (at the first comphcation that occurred
dunng follow-up) or control only once As the risk of
comphcations is obviously related to the type of interven
tion we matched cases and controls äs a group accordmg to
the category of the Intervention
Data collection We mcluded the followmg Information
from the computenzed records of the Leiden Anticoagula-
tion Clinic date of birth sex and the mdications for oral
anticoagulant therapy and hospital admission The date of
the surgical Intervention was retneved from the medical
chart along with results of the blood tests for the level of oral
anticoagulation before and after the Intervention These
levels äs measured by prothrombin times were expressed in
international normalized ratio (INR) which is the mterna
tional Standard (International Committee for Standardiza
tion in Hematology International Committee on
Thrombosis and Hemostasis 1982) For each case we also
registered the date of the comphcation and relevdnt results
of laboratory tests X rays computed tomography (CT)
scans and autopsy reports As we studied the role of
the achieved level of anticoagulation on the day of
the comphcation we used for the controls the INR value
on the day the matching case had his comphcation
There is a wide ränge of clinical practice towards the
preoperative discontmuation of anticoagulants Therefore
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Table I Classification of interventions





































































we chose to disregard the methods that were applied to
lower the anticoagulation level and studied only the INRs
that were achieved In our hospital no intravenous hepann
is admimstered m anticoagulated patients prior to surgical
interventions except m rare cases and then only in those
with artifical heart valves
Comphcations Haemorrhages (intracramal spinal and
extracramal) and thromboembohc comphcations (ischaemic
stroke myocardial infarction and artenal penpheral embol-
ism) that occurred m the penoperative phase were the
events of mterest The incidence of venous thromboembo-
hsm was not studied All comphcaüons were reviewed by an
expert panel of physicians who were blmded to the INR
accordmg to the followmg defimtions
Intracramal and spinal haemorrhage was defined äs a
neurological deficit of sudden or subacute onset conflrmed
by surgery autopsy or CT scan Extracramal haemorrhage
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was deflned äs severe blood loss, leading to prolonged
hospital admission, blood transfusion, additional diagnostic
or therapeutic interventions or death. Ischaemic stroke was
included äs a neurological deflcit of acute onset, proved by
autopsy or CT scan. Strokes that could not be categorized
were registered äs 'unclassified stroke'. Myocardial infarc-
tion was defined by two or more of the following: history of
ehest discomfort, typical rise of speciflc cardiac enzymes or
the development of new Q waves on electrocardiogram. The
diagnosis of arterial peripheral erabolism required sudden
peripheral ischaemia, proved by duplex scanning, angiog-
raphy, surgery or autopsy.
Analysis
Frequencies and their 95% confldence interval (CI) were
derived by Standard calculations, based on the assumption
of a Poisson distribution of the number of events. To assess
the effect of patient characteristics and the level of antico-
agulation on the occurrence of complications, we calculated
odds ratios (OR) äs a measure of the relative risk by means
of logistic regression models. As cases and controls were
matched on the type of surgery, the category of the
Intervention remained a variable in the applied logistic
model a t all times.
RESULTS
Complications
Seventy-two complications occurred among the 603 med-
ical and surgical interventions in the Leiden University
Medical Centre. As only first events were taken into account
for the nested case-control study, 70 complications
remained for this purpose. We selected two controls per
case for all interventions except thoracic surgery, äs only 63
controls were available in this category.
Incidence rates of complications per Intervention cate-
gory are given in Table II. The overall frequency of bleeding
and thromboembolic events related to surgery was 11-9%
(95% CI 9-3-14-9), 9-5% (n = 57) for haemorrhage and
2-5% (n = 15) for thromboembolism. Frequencies varied
between the Intervention categories, from a minimum of
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Fig 1. Frequency of complications according to perioperative day
dures (thoracic surgery). Two-thirds of all events occurred
within 48 h after the Intervention, at a ränge of -l to
20 days, äs shown in Fig 1.
More detailed Information on the complications is
presented in Table III. Fifty of the 5 7 bleeding events were
located at the Operation site. Six of the other seven
haemorrhages had a gastrointestinal origin whereas one
patient died from a retroperitoneal bleed after coronary
bypass surgery. Fifteen thromboembolic events occurred.
Eight patients had a myocardial infarction and five ischae-
mic stroke, all but one in the postoperative phase. One
patient had a thrombosis of the renal artery 4 days after
cardiac catheterization. We also registered a transient
ischaemic attack during coronary angiography. As no CT
scanning was performed, this complication was registered
äs unclassified stroke although the signs and Symptoms
pointed towards a thromboembolic event. The patient made
a füll recovery, äs did the five patients with a proven
cerebral infarction.
Risk estimates of patient characteristics
Table IV gives the results of the nested case-control study
we performed on patient characteristics by comparing 70
patients with a perioperative event to 135 controls.




























































Categories are deflned in Table I.
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Table III. Detailed Information on penoperative events
Bleedmg
Fatal
At the Operation Site
Other
Non-fatal
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None of the patient charactenstics exammed - age, sex
and the mdication for anticoagulant therapy - was
strongly associated with the occurrence of comphcations
However, younger patients (< 65 years of age) tended to
have more untoward events compared with the elderly
(OR 16, 95% CI 09-29), whereas patients with atnal
fibnllation appeared to have a higher nsk compared with
those treated because of a mechanical heart valve (OR
l 5, 95% CI 0 7-3 4) Both effects were mamly caused by
an increased thromboembohc nsk Multivanate analysis,
m which the odds ratlos were adjusted for the other
patient charactenstics, made the umvanate outcomes
more exphcit
Risk estimates of the level of anticoagulatwn
We studied the role of the achieved levels of oral anticoag-
ulation on the day of the Intervention, at the time the
comphcation occurred and over the penod between the day
of surgery and the comphcation The results are presented
m Table V
On the day of surgery, the INR levels of the cases vaned
between l 2 and 4 9 INR (mean 2 2 INR) Fifty-four per cent
of the mtensities were <2 0 INR, which is the target ceiling
for many mterventions The level of anticoagulation on the
day of the Intervention was not related to the occurrence of
































































0 6 (0 3-1 1)
10




0 9 (0 4-1 7)
10
1 1 (0 5-2 3)
1 5 (0 7 34)
10
1 0 (0 5-2 3)




Adjusted OR (95% CI)t
10
0 5 (0 3-1 0)
10
0 6 (0 3-1 3)
10
0 3 (0 1-1 1)
10
0 9 (0 4-1 8)
10
1 1 (0 5-2 4)
1 8 (0 8-4 2)
10
1 1 (0 5-2 4)
1 5 (0 6-3 7)
10
2 2 (03-154)
5 3 (0 7-38 9)
*0dds ratios adjusted for the category of the Intervention only
tOdds ratios adjusted for the category of the Intervention äs well äs for age sex and mdication
MHV mechanical heart valve MI myocardial infaiction AF atnal fibrillafaon
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Table V. Risk factors odds ratios for different mtensities of anücoagulation
Gases (n) Controls (n) Crude OR (95% CI)*
INR on the day of the comphcation
All events
Adjusted OR (95% CI)t






















1 0 (0 5-2 2)
09(04-23)
10
1 1 (0 5-2 4)
1 1 (0 4-2 9)
10
1 0 (0 5-2 1)
0 9 (0 4-2 3)
10
1 0 (0 5-2 4)












1 0 (0 3-3 6)
03 (00-3 1)
10
0 7 (0 2-2 9)













































1 0 (0 5-2 2)
1 1 (0 5-2 4)
10
1 2 (0 5-2 8)
1 4 (0 6-3 4)
10
0 8 (0 2-2 7)
0 3 (0 0-2 3)
of the comphcation
10
1 0 (0 4-2 3)
1 4 (0 6-3 1)
10
1 2 (0 5-3 3)
1 7 (0 7-4 1)
10
0 5 (0 1-2 5)
1 0 (0 7-4 1)
10
10 (04-2 1)
1 1 (0 5-2 6)
10
1 ] (0 5-2 7)
1 3 (0 5-3 4)
10
0 5 (0 1-2 2)
0 2 (0 0-1 9)
10
0 9 (0 4-2 2)
1 3 (0 6-3 0)
10
1 1 (0 4-3 0)
1 6 (0 6-4 0)
10
0 5 (0 1-2 6)
0 7 (0 2-2 9)
INR international normahzed ratio
*0dds ratios adjusted for the category of the Intervention only
tOdds ratios adjusted for the category of the Intervention, äs well äs for age, sex and mdication
a comphcation afterwards, äs shown by odds ratios of l 0
(95% CI 0 5-2 2) for levels between 2 and 3 INR and 0 9
(95% CI 0 4-2 3) for INR values >3
The anticoagulation levels on the day of the comphcation
varied between l l and 120 INR (mean 2 6 INR) Sixty-one
per cent of the INR values were 2 0 or higher Twenty-seven
per cent was even higher than 3 0 INR However, patients
without a comphcation had no different INRs than the
patients with a comphcation had on the days of the
comphcation 62% INR >2 0, 27% INR >3 0 Thus, INR
values on the day of the comphcation did not differ between
cases and controls for all comphcations combmed (OR l 0,
95% CI 0 5-2 2 for INR 2-3, OR l l, 95% CI 0 5-2 4 for
INR >3) Higher anticoagulation levels (INR > 3) tended to
be associated with bleedmg events (OR 14, 95% 0 6-3 4)
whereas at the same time thromboembohsm was prevented
(OR03, 95% CIO 0-2 3)
As we studied the mfluence of the highest achieved
intensity level over a longer penod - from the day betöre
the Intervention until the day the comphcation occurred,
with a maximum of l week - only the highest values
(INR > 3) seemed to be associated with a shghtly increased
nsk of comphcations (OR l 4, 95% CI 0 6-3 1) As very
few individuals had INRs over 5 (flve oi 64 patients, nme
of 135 controls), we could not estimate the nsk durmg
high INRs
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Multivariate analysis, in which we adjusted the effects of
the INR values for age, sex and the indication for treatment,
did not alter the outcomes essentially äs shown in the last
line of Table V.
DISCUSSION
Anticoagulant therapy in non-routine situations such äs
surgery raises clinical questions äs how to minimize the
risk of postoperative haemorrhage without compromising
the prevention of thromboembolic events. As so little is
known about the risks of surgery in anticoagulated
patients, we decided to investigate the frequency of
perioperative complications and study potential risk factors
for events. The frequency of major haemorrhage and
thromboembolism was high in the perioperative period
(11-9 events per 100 interventions, 95% CI 9-3-14-9),
especially in ehest surgery. Bleeding complications
occurred most frequently (9-5 per 100 events, 95% CI
7-1-12-1) and these were most frequently located at the
Operation site or in the gastrointestinal tract. Two-thirds of
all events occurred within 48 h after the Intervention.
Neither patient characteristics - sex, age and the indica-
tion for anticoagulant therapy - nor the level of antico-
agulation in the perioperative phase appeared to play a
major role in the occurrence of complications.
Frequency of haemorrhage and thromboembolism
The frequency of perioperative complications varied
between the different categories of interventions. Eye
surgery and orthopaedic interventions appeared to have a
low risk of complications where äs many äs one-third of all
patients undergoing thoracic surgery suffered an untoward
event. These differences can, for the greater part, be
explained by the nature of the interventions and the applied
anticoagulant treatment.
Most eye surgery is performed in the relative absence of
blood vessels, which makes haemorrhage an uncommon
complication (Gainey et al, 1989). Moreover, oral antico-
agulation on the day of surgery was reduced to levels below
2-0 INR for all 53 interventions (mean 1-4 INR). In the
orthopaedic patients, the average anticoagulation level on
the day of surgery was 1-6 INR and in the first postoperative
week the INR was 2-2.
Thoracic surgery, which mainly consisted of coronary
bypass and heart valve surgery, is characterized by exten-
sive (micro) vascular surgery and a high proportion of acute
interventions. The need for extracorporeal circulation
induces platelet dysfunction and firm anticoagulation is
applied to keep grafts open and avoid valve thrombosis äs
illustrated by an average INR of 2-6 on the day of surgery
and a mean INR of 3-3 in the first postoperative week. All
these qualities might have contributed to the high risk of
postoperative complications in this category.
The overall frequency of perioperative complications was
11-9% over 24 days, which is equivalent to an incidence of
181 events per 100 patient-years. As the average annual
risk of all combined untoward events in our patient
group was 4-7% (ASPECT Research Group, 1994; Atrial
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Fibrillation Investigators, 1994; Cannegieter et al, 1995),
surgery increased this risk 25^5-fold. Even when thoracic
surgery, with its extreme complication rate, was set aside,
the frequency of untoward events remained high (7-4 per
100 interventions, 95% CI 5-2-10-1). We therefore con-
clude that routine surgery in anticoagulated patients yields
a high risk, of which physicians must be aware.
Risks
Patient characteristics. The patient characteristics we
examined did not much influence the risk of complications.
The higher frequency among patients treated for atrial
fibrillation might be the result of the fact that atrial
fibrillation is often related to other cardiac diseases, such
äs impaired left ventricular function, valve disease or
cardiac ischaemia. Hence, the vulnerability to thromboem-
bolism in these patients is increased. The different compli-
cation rates between the three patient groups in our study
were mainly caused by an increased risk of thromboembolic
events whereas the bleeding risk remained constant, which
Supports this hypothesis.
A considerable cardiovascular bürden might also account
for the high complication risk among younger patients. As
patients suffer from cardiovascular disease at a relatively
young age, their disease might follow a more malignant
course that makes them more susceptible to thromboem-
bolic events.
Level of anticoagulation. The achieved level of oral antico-
agulation in the perioperative period appeared to play only a
minor role in the causal mechanism leading to the overall
risk of complications in relation to surgery. However, when
bleeding and thromboembolic events were studied sepa-
rately, higher anticoagulation levels tended to be associated
with bleeding whereas lower INR values favoured throm-
boembolism.
We found that INR on the day of the Intervention did not
predict the occurrence of a complication, indicating that
local factors are of much more importance at this stage. This
observation was confirmed by the finding that patients who
actually experienced their untoward event in the first 24 h
had similar levels of anticoagulation äs the controls. Our
data suggest an effect of the highest anticoagulation levels
in the period preceeding a complication: INR values over 3-0
seemed to be related to a higher risk of events (OR 1-4, 95%
CI 0-6-3-1).
A shortcoming of our study was that we could not
identify those patients who received intravenous heparin in
the perioperative phase. However, the general practice in
the Leiden University Medical Centre is to refrain from
treatment with heparin when oral anticoagulation is
reversed. Exceptions to this practice are few and are
mainly limited to patients who underwent heart valve
surgery and did not reach an adequate postoperative INR
level in time. We therefore do not believe that the outcomes
of our study were essentially altered by the lack of data on
heparin use. A reliable comparison of the high bleeding risk
in our study to the average perioperative bleeding risk was
prohibited by the wide variety of surgical procedures we
studied.
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Recommendations
We conclude that one in 10 medical or surgical interven-
tions m anticoagulated patients is complicated by a haem-
orrhagic or thromboembolic event. Although the level of
anticoagulation appeared to be just a small part of the
causal mechanism that leads to the occurrence of comph-
cations, high penoperative levels (INR > 3) should be
avoided, m which the days followmg surgery are at least
äs important äs the day of the Intervention itself In
particular, patients with atrial flbnllation are highly prone
to expenence a thromboembolic event and should be
anticoagulated with the utmost consideration
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